Top 12 Biomedical Engineering Investors in Latin America
Top 12 Biomedical Engineering Investors in Latin America
Biomedical engineering in Latin America is an expanding sector focused on developing technologies and solutions that enhance patient care and outcomes. Companies range from startups specializing in medical devices to established firms producing innovative biotech products. With increased demand for healthcare solutions, the industry emphasizes advancements in telemedicine, wearable health tech, and regenerative medicine. Trends toward personalized medicine and digital health are reshaping market dynamics, fueled by a young, tech-savvy population. Collaborations with international partners and increased venture capital investments are expected to propel the sector's growth and innovation, making it an exciting area for investors and entrepreneurs alike.
The investor landscape in Latin America's biomedical engineering industry comprises mainly venture capital firms and corporate investors, with headquarters concentrated in Sao Paulo and Santiago. Founded within the last decade, these firms range in size from small teams of fewer than ten to larger groups with up to fifty members. Across 2024, these investors collectively executed numerous deals, showcasing their commitment to funding biomed innovations. Among them, Kptl, Eretz.bio, and DNA Capital stood out for their substantial investments, reflecting a robust ecosystem eager to support emerging technologies and companies in this vital sector.
Top 12 Biomedical Engineering Investors in Latin America
1. bossa invest
- Website: bossainvest.com
- Type: Venture Capital
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2011
- Headcount: 11-50
- Number of deals in 2024: 56
- LinkedIn: bossainvest
Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in the technology sector, and has a strong focus on empowering entrepreneurs through capital, strategic guidance, and access to a network of co-investors. Notably, Bossa Invest has participated in significant transactions in the biomedical engineering field, including a $13.2 million Series A investment in Vicarious Surgical, a company that develops robotic surgical systems. Additionally, they were involved in funding rounds for Ossium Health, a therapeutics company focused on stem cell therapies, which raised $63 million in Series B funding. Their investment in Empatica, a company that develops wearable devices for health monitoring, further underscores their engagement in the biomedical sector. Through these investments, Bossa Invest demonstrates a commitment to fostering growth in the startup ecosystem, particularly in areas that intersect with healthcare and technology.
2. Eretz.bio
- Website: eretz.bio
- Type: Corporate
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2017
- Headcount: 11-50
- Number of deals in 2024: 16
- LinkedIn: eretz.bio
Eretz.bio is a not-for-profit organization founded in 2017, located in Sao Paulo, Brazil. It operates as an innovation hub associated with the Hospital Israelita Albert Einstein, focusing on incubating startups in the healthcare sector. Eretz.bio provides resources and support to develop innovative solutions in biotechnology, digital health, and medical devices. Notably, they have been involved in several relevant transactions, including funding for Hefesto Medtech, which focuses on medical technology, and RioGen, which is likely engaged in biotechnological advancements. Their active investment in these areas highlights their commitment to fostering innovation in biomedical engineering.
3. GRIDS Capital
- Website: gridscapital.com
- Type: Venture Capital
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2016
- Headcount: 1-10
- Number of deals in 2024: 1
- LinkedIn: grids-capital
GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures, focusing on providing investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital aims to build a diverse portfolio that supports innovation and development across various industries, including artificial intelligence and life sciences. Notably, they have participated in significant funding rounds for companies in the biomedical engineering sector, such as BigHat Biosciences, which raised $75 million to enhance its AI/ML-wet lab platform for biotechnology applications. They also invested in Immusoft, a biotech startup developing gene therapy technology, and CytoVale, which focuses on early detection of sepsis. These transactions highlight GRIDS Capital's active role in advancing biomedical technologies and their commitment to fostering innovation in the life sciences.
4. The Ganesha Lab
- Website: theganeshalab.com
- Type: Corporate
- Headquarters: Las Condes, Santiago, Chile
- Founded year: 2016
- Headcount: 1-10
- Number of deals in 2024: 5
- LinkedIn: ganeshalab
The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It focuses on supporting early-stage biotech startups in Latin America through various programs such as BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate the complexities of the biotech industry and scale their innovations for global impact. Notably, they have been involved in several transactions relevant to the biomedical engineering field, including investments in Smart Tissues, which focuses on tissue engineering, and Tensor Care, which develops healthcare solutions. Additionally, they supported Pannex Therapeutics Inc., a company that may be involved in therapeutic innovations, further emphasizing their commitment to advancing biotech solutions that can impact biomedical engineering.
5. DNA Capital
- Website: dnacapital.com
- Type: Venture Capital
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2013
- Headcount: 11-50
- Number of deals in 2024: 1
- LinkedIn: dna-capital-br
DNA Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support aimed at fostering growth and innovation in the healthcare sector. DNA Capital has been involved in several notable transactions relevant to biomedical engineering, including a $30 million Series A investment in Spotlight Therapeutics, which focuses on therapeutic solutions, and a $30 million Series C investment in Cambridge Epigenetix, a company that develops epigenetic technologies. Additionally, they invested approximately $200 million in Inspirali, which is involved in medical education, and participated in a funding round for Arterys, a company that utilizes AI in medical imaging. These investments highlight DNA Capital's commitment to advancing healthcare technologies, making them a significant player in the biomedical engineering landscape.
6. Kptl
- Website: kptl.com.br
- Type: Venture Capital
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2020
- Headcount: 11-50
- Number of deals in 2024: 5
- LinkedIn: inseed-investimentos
KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in the investment landscape, KPTL has made more than 124 investments, focusing on innovative startups across various industries. Among their notable transactions in the biomedical engineering context are investments in Celer Biotecnologia, which raised $857,480 in Series A funding in 2008, and Magnamed, which secured $2,606,090 in Series A funding in 2008. Additionally, they invested in Tmed, which also raised funds in Series A, and Vida Biotecnologia, which received venture funding in 2012. More recently, they invested in Omics Animal Biotechnology in 2023, further demonstrating their ongoing commitment to the biotechnology sector.
7. IKJ Capital
- Website: ikj.capital
- Type: Venture Capital
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2019
- Headcount: 1-10
- Number of deals in 2024: 7
- LinkedIn: irukandji-capital
IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investing in early-stage healthcare technology companies, aiming to tackle significant healthcare challenges. In 2024 alone, IKJ Capital has participated in seven investments, demonstrating their active role in the healthcare sector. Notable transactions include a $7 million seed round for Portal and a $5 million pre-seed round for the same company, indicating their support for innovative healthcare solutions. Additionally, they invested in Perceiv AI, which is expanding its Prognostic Platform Foresight(TM) with the help of strategic and institutional investors, showcasing their commitment to advancing healthcare technology. Their involvement in these transactions highlights their focus on supporting startups that are likely to contribute to advancements in biomedical engineering.
8. Cites
- Website: cites-gss.com
- Type: Venture Capital
- Headquarters: Sunchales, Santa Fe, Argentina
- Founded year: 2014
- Headcount: 51-200
- Number of deals in 2024: 2
- LinkedIn: cites
Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting the development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources. Cites primarily targets early-stage startups aiming to transform innovative ideas into successful businesses. Notably, Cites has made significant investments in the biomedical engineering context, including Limay Biosciences, which raised $600,000 in a seed round in August 2022, and NeuroAcoustics, which raised an undisclosed amount in January 2024. Other relevant transactions include Bionirs and RadBio, both of which are involved in biotechnology, and Viewmind, which raised $1,000,000 in September 2020. These transactions highlight Cites' commitment to fostering innovation in the biomedical engineering sector.
9. Zentynel Frontier Investments
- Website: zentynel.com
- Type: Venture Capital
- Headquarters: Santiago, Santiago, Chile
- Founded year: 2017
- Headcount: 1-10
- Number of deals in 2024: 4
- LinkedIn: zentynel-frontier-investments
Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in the sector. Zentynel has been involved in several notable transactions, including a $10 million Series A-1 financing for Autem Therapeutics, which is focused on developing a novel bioelectric oncology treatment platform for solid tumors. They also participated in a seed funding round for MultiplAI Health, a diagnostics company, raising $2.7 million to support technical validation and expansion efforts. These transactions highlight Zentynel's commitment to supporting high-growth potential companies in the biotechnology and biomedical engineering sectors.
10. Crescera Capital
- Website: crescera.com
- Type: Private Equity
- Headquarters: Rio De Janeiro, Rio De Janeiro, Brazil
- Founded year: 2008
- Headcount: 11-50
- Number of deals in 2024: 7
- LinkedIn: bozano-investimentos
Crescera Capital is a private equity and venture capital investment firm based in Rio de Janeiro, Brazil, founded in 2008. The firm specializes in providing growth capital and strategic guidance to mid-sized companies across various sectors, including education, technology, and health. Notably, Crescera has made significant investments in the biomedical engineering space, with transactions such as Ventrix, which raised $1,770,907 in a seed round in 2015, and Confiance Medical S/A, which raised $793,248 in a seed round in 2017. Additionally, they invested in Compass, a company that received funding in both 2016 and 2017, further demonstrating their interest in health-related technologies. In 2023, Crescera also participated in a private equity round for Hospital Care, indicating their ongoing commitment to enhancing operational performance in the health sector.
11. VOX Capital
- Website: voxcapital.com.br
- Type: Venture Capital
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2009
- Headcount: 11-50
- Number of deals in 2024: 1
- LinkedIn: vox-capital
VOX Capital is an impact investment firm based in Sao Paulo, Brazil, founded in 2009. The firm specializes in managing investments that generate positive social and environmental outcomes, focusing on sectors such as healthcare, education, and climate solutions. VOX Capital serves both individual and institutional investors who seek to align their financial goals with their values. Among their notable transactions, they invested in Magnamed, which raised funds in 2015, and ProRadis, which secured $1.9 million in Series A funding in 2015. Additionally, they participated in a Series A round for Sanar, a Brazilian healthcare edtech startup, which aims to improve healthcare outcomes for low-income patients. These investments highlight VOX Capital's commitment to enhancing healthcare, making them a relevant player in the biomedical engineering space.
12. AIR Capital
- Website: aircapital.vc
- Type: Corporate
- Headquarters: Buenos Aires, Buenos Aires, Argentina
- Founded year: 2021
- Headcount: 1-10
- Number of deals in 2024: 13
- LinkedIn: air-capital-vc
AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm focuses on early-stage startups that are driving disruptive innovations relevant for humanity. With a small team of 1-10 members, AIR Capital has made 13 investments in 2024 alone, showcasing their active engagement in the startup ecosystem. Their portfolio includes a variety of startups across different sectors, emphasizing their commitment to fostering innovation. Notably, AIR Capital has invested in companies such as Aplife Biotech and Tissue Dynamics, which are involved in biotechnology and medical technology, respectively. These investments highlight AIR Capital's interest in the biomedical engineering field, as they support companies that are developing solutions with significant implications for healthcare and medical advancements.
Biomedical Engineering Insights: Key Investors in Latin America
| Investor | Headquarter | Size | Founded | Deals 2024 |
|---|---|---|---|---|
| bossa invest | Sao Paulo, Sao Paulo, Brazil | 11-50 | 2011 | 56 |
| Eretz.bio | Sao Paulo, Sao Paulo, Brazil | 11-50 | 2017 | 16 |
| GRIDS Capital | Sao Paulo, Sao Paulo, Brazil | 1-10 | 2016 | 1 |
| The Ganesha Lab | Las Condes, Santiago, Chile | 1-10 | 2016 | 5 |
| DNA Capital | Sao Paulo, Sao Paulo, Brazil | 11-50 | 2013 | 1 |
| Kptl | Sao Paulo, Sao Paulo, Brazil | 11-50 | 2020 | 5 |
| IKJ Capital | Sao Paulo, Sao Paulo, Brazil | 1-10 | 2019 | 7 |
| Cites | Sunchales, Santa Fe, Argentina | 51-200 | 2014 | 2 |
| Zentynel Frontier Investments | Santiago, Santiago, Chile | 1-10 | 2017 | 4 |
| Crescera Capital | Rio De Janeiro, Rio De Janeiro, Brazil | 11-50 | 2008 | 7 |
| VOX Capital | Sao Paulo, Sao Paulo, Brazil | 11-50 | 2009 | 1 |
| AIR Capital | Buenos Aires, Buenos Aires, Argentina | 1-10 | 2021 | 13 |
Want to find more investors focusing on the biomedical engineering industry?
If you want to find more investors that are active in the biomedical engineeringindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.With Inven, you'll also get to know:
- Deal History: Number of deals and their sizes.
- Portfolio: Companies they've invested in.
- Contact data: Key dealmakers, including their emails and phonenumbers.
- ...and much more!
.jpg)
Trusted by 700+ companies
